These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1971439)

  • 1. Antinociceptive cross-tolerance between [D-Arg2]-dermorphin tetrapeptide analogs and morphine.
    Chaki K; Sakurada S; Sakurada T; Nakata N; Kisara K; Watanabe H; Suzuki K
    Peptides; 1990; 11(1):139-44. PubMed ID: 1971439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the antinociceptive effects of new [D-Arg2]-dermorphin tetrapeptide analogs and morphine in mice.
    Chaki K; Sakurada S; Sakurada T; Sato T; Kawamura S; Kisara K; Watanabe H; Suzuki K
    Pharmacol Biochem Behav; 1988 Oct; 31(2):439-44. PubMed ID: 2907624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal tetrapeptide of dermorphin and D-Arg-substituted tetrapeptides: inactivation process of the antinociceptive activity by peptidase.
    Chaki K; Sakurada S; Sakurada T; Kisara K; Suzuki K
    Life Sci; 1990; 46(23):1671-8. PubMed ID: 1972532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of opioid activity between a N-terminal tetrapeptide analogue of dermorphin, H-Tyr-D-Arg-Phe-beta-Ala-OH and morphine.
    Sato T; Takahashi N; Tan-No K; Kisara K; Sakurada T; Sakurada S
    Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):581-6. PubMed ID: 9819802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance and cross-tolerance to the antinociceptive effects of [D-Arg2]-dermorphin tetrapeptide analogue and morphine.
    Sakurada S; Nakata N; Sakurada T; Chaki K; Kawamura S; Kisara K; Suzuki K
    Neuropharmacology; 1993 Jul; 32(7):689-93. PubMed ID: 8361582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analgesic activity of D-Arg2-dermorphin and its N-terminal tetrapeptide analogs after subcutaneous administration in mice.
    Sasaki Y; Matsui M; Fujita H; Hosono M; Taguchi M; Suzuki K; Sakurada S; Sato T; Sakurada T; Kisara K
    Neuropeptides; 1985 Feb; 5(4-6):391-4. PubMed ID: 2860597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance and dependence following chronic intracerebroventricular infusions of Tyr-D-Arg2-Phe-Sar4 (TAPS).
    Vonhof S; Gudka BD; Sirén AL
    Eur J Pharmacol; 2003 Jan; 459(1):41-8. PubMed ID: 12505532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociception and physical dependence produced by [D-Arg2] dermorphin tetrapeptide analogues and morphine in rats.
    Chaki K; Kawamura S; Kisara K; Sakurada S; Sakurada T; Sasaki Y; Sato T; Susuki K
    Br J Pharmacol; 1988 Sep; 95(1):15-22. PubMed ID: 2905901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermorphin tetrapeptide analogs as potent and long-lasting analgesics with pharmacological profiles distinct from morphine.
    Mizoguchi H; Bagetta G; Sakurada T; Sakurada S
    Peptides; 2011 Feb; 32(2):421-7. PubMed ID: 21126548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new class opioid peptide, [D-Arg2, beta-Ala4]-dermorphin tetrapeptide; physical dependence liability in mice.
    Chaki K; Sakurada S; Sakurada T; Sato T; Kawamura S; Kisara K; Sasaki Y; Suzuki K
    Neuropeptides; 1989; 13(2):83-8. PubMed ID: 2567974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-Arg2-dermorphin tetrapeptide analogs: a potent and long-lasting analgesic activity after subcutaneous administration.
    Sasaki Y; Matsui M; Taguchi M; Suzuki K; Sakurada S; Sato T; Sakurada T; Kisara K
    Biochem Biophys Res Commun; 1984 Apr; 120(1):214-8. PubMed ID: 6712689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical dependence of a dermorphin tetrapeptide analog, [D-Arg2, Sar4]-dermorphin (1-4) in the rat.
    Nakata N; Sakurada S; Sakurada T; Kisara K; Sasaki Y; Suzuki K
    Pharmacol Biochem Behav; 1986 Jan; 24(1):27-31. PubMed ID: 3945663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors.
    Riba P; Ben Y; Smith AP; Furst S; Lee NM
    J Pharmacol Exp Ther; 2002 Jan; 300(1):265-72. PubMed ID: 11752125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues.
    Marastoni M; Salvadori S; Balboni G; Borea PA; Marzola G; Tomatis R
    J Med Chem; 1987 Sep; 30(9):1538-42. PubMed ID: 2887656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal antinociception: comparison of a dermorphin tetrapeptide analogue, [D-arginine2, sarcosine4]-dermorphin (1-4) and morphine in rats.
    Nakata N; Sakurada S; Sakurada T; Kawamura S; Kisara K; Suzuki K
    Neuropharmacology; 1990 Apr; 29(4):337-41. PubMed ID: 2342636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermorphin analogues containing D-kyotorphin: structure-antinociceptive relationships in mice.
    Kisara K; Sakurada S; Sakurada T; Sasaki Y; Sato T; Suzuki K; Watanabe H
    Br J Pharmacol; 1986 Jan; 87(1):183-9. PubMed ID: 2869809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid activities of D-Arg2-substituted tetrapeptides.
    Sato T; Sakurada S; Sakurada T; Furuta S; Chaki K; Kisara K; Sasaki Y; Suzuki K
    J Pharmacol Exp Ther; 1987 Aug; 242(2):654-9. PubMed ID: 3612556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier permeability of novel [D-arg2]dermorphin (1-4) analogs: transport property is related to the slow onset of antinociceptive activity in the central nervous system.
    Deguchi Y; Naito Y; Ohtsuki S; Miyakawa Y; Morimoto K; Hosoya K; Sakurada S; Terasaki T
    J Pharmacol Exp Ther; 2004 Jul; 310(1):177-84. PubMed ID: 15031301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.